Strategic Partnerships

Takeda logo
Takeda Pharmaceutical Company and BioMotiv have formed a strategic partnership that will leverage the strengths of both organizations to identify and develop pioneering medical innovations in the therapeutic areas of Immunology & Inflammation and Oncology.
Biogen
Biogen and BioMotiv have formed a strategic partnership that will leverage the strengths of both organizations to identify and develop pioneering medical innovations in the therapeutic areas of Neurology and Ophthalmology.
Arix Bioscience Logo
Arix Bioscience, a global healthcare and life science company supporting medical innovation, and BioMotiv have formed a strategic investment partnership. Arix Bioscience was founded by leading figures in the international healthcare and life science sectors including Dr Joe Anderson, Chief Executive Officer, Jonathan Peacock, Chairman, and Professor Sir Christopher Evans, OBE, Deputy Chairman, and is backed by Woodford Investment Management and other institutional investors. Arix has the opportunity to co-invest and further develop BioMotiv portfolio companies, and BioMotiv will be able to leverage Arix’s renowned leadership team, extensive networks, and unique development platform. Working together, Arix and BioMotiv will enable wide ranging support for innovative university-sourced discoveries, accelerating them into novel medicines.
Charles River Logo
Charles River Laboratories and BioMotiv have formed a partnership that will leverage the strengths of both organizations to advance discoveries sourced from academic research and non-governmental organizations into novel medicines. Charles River Laboratories will be the preferred partner for preclinical drug development programs of BioMotiv and its companies.